StockData
Sinovac Biotech Ltd logo

Sinovac Biotech Ltd (SVA) stock

SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 5, 2026Score 7/30
$6.47+0.00 (0.00%)

Close on Nov 18, 2026Market cap $464.94MP/E –Yield 850.08%

Sinovac Biotech shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 72M, up 0.0% from the year before. Over ten years it grew 2.5% a year on average. The highest annual figure on record is 114M in fiscal 2020.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202572M0.0%
FY2024Dec 31, 202472M+0.0%
FY2023Dec 31, 202372M+0.1%
FY2022Dec 31, 202272M+0.2%
FY2021Dec 31, 202172M-37.0%
FY2020Dec 31, 2020114M+3.6%
FY2019Dec 31, 2019110M+68.8%
FY2018Dec 31, 201865M+13.8%
FY2017Dec 31, 201757M+0.3%
FY2016Dec 31, 201657M+1.1%
FY2015Dec 31, 201556M+0.4%
FY2014Dec 31, 201456M+0.6%
FY2013Dec 31, 201356M+1.6%
FY2012Dec 31, 201255M+0.6%
FY2011Dec 31, 201155M+2.9%
FY2010Dec 31, 201053M+23.5%
FY2009Dec 31, 200943M–

More Sinovac Biotech figures

See a number that looks wrong?